Investing in the prosperity of everyone

Investing in the prosperity of everyone

We are working with our partners to tackle today's greatest health challenges. One of these is making affordable and highquality healthcare accessible to all people worldwide. Because only then can we achieve our goal: a future in which diseases are a thing of the past. That is why we take personal responsibility at Janssen and commit ourselves to the well-being of everyone, everywhere in the world.

PROSPERITY

BEING HEALTHY. A BASIC RIGHT FOR EVERYONE IN THE WORLD As a health company, we seek solutions for the greatest medical needs of vulnerable communities both around the world and closer to home. These solutions must be affordable, available and sustainable. That is why we commit ourselves, day in and day out, to making our medicines available to the widest possible group of people.

OUR SOCIAL FOOTPRINT

Innovation and speed at the cutting edge. The COVID-19 approach.

IMMUNOLOGY

ONCOLOGY

NEUROSCIENCE

INFECTIOUS DISEASES & VACCINES

PULMONARY HYPERTENSION

CARDIOVASCULAR & METABOLISM

We are investing in our partnerships and expertise to find a candidate vaccine and a suitable treatment for COVID-19, as quickly as possible.

We are also taking concrete actions that support the population and healthcare.

For example, by manufacturing disinfectant hand gel, by performing COVID-19 diagnostic tests in Belgium, or by focusing on psychosocial support for primary care providers. We also give employees with medical training the opportunity to carry out voluntary work during working hours.

We achieve minor and major medical breakthroughs in each of our six focus areas.

Our goal is to ensure that everyone in the world has equal access to available medicines and the best opportunities for a healthy and long life.

/JanssenBelgium

/JanssenBelgium

/janssen-belgium

/janssen.benelux

PROSPERITY

OUR ECONOMIC FOOTPRINT Our medicines can only do their job when they actually reach the patient. That is why we focus on effective distribution and an optimal infrastructure. By doing so, we speed up development and production through innovation.

Partnerships at the heart of our strategy We work closely with universities, research institutes, patient organizations, doctors, hospitals, industry and NGOs to continuously improve patient care and health outcomes.

Themes we focus on in our partnerships are:

Talent Innovation Digitization

Ecology

Sustainable Development Goals Clinical studies

82 PhD and Postdoc students employed JOHNSON & JOHNSON INNOVATION - JLABS @ BEERSE

150 interns per year (Bachelors & Masters)

We support healthcare start-ups via funding, knowledge and a broad network.

Our campus is visited by 400 PhD students & 800 Bachelors and Masters students every year

21 current start-ups 46% led by women â‚Ź 94,8m million in financing and strategic relationships

* Figures: summer 2020 - In cooperation with Leuven Catholic University, Ghent University and Liège University

PROSPERITY

INVESTING IN THE WELL-BEING OF OUR PEOPLE

UNIQUE PARENTAL SCHEME We want our employees to feel good, both mentally and physically, in their job. As an employer, we make an active effort to achieve this.

An example of this is our unique parental scheme New parents, including fathers, are entitled to eight weeks of paid parental leave at Janssen, which they can also use flexibly.

5.100+ STAFF

46%

MOST ATTRACTIVE

54%

private sector employer OF THE DECADE

55+

NATIONALITIES

Janssen Pharmaceuticals is the only company in Belgium that has always managed to score in the top ten in the survey of the most attractive employer since it began (2000).

In addition, in 2020 we received the Randstad award for the most attractive employer of the decade for the second time.

Š Janssen-Cilag NV - EM - 46488 - 6 nov 2020 - vu/er Luc van Oevelen, Antwerpseweg 15-17, 2340 Beerse

This arrangement allows new parents to spend more time with their family at times of their choosing, and allows both partners to better distribute the care of the child.